← Back to Search

EPPCom Provider Training for Chronic Kidney Disease (EPPComm Trial)

N/A

Recruiting

Led By Francis Weng, MD

Research Sponsored by Temple University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, 4 years

Awards & highlights

EPPComm Trial Summary

This trial aims to study the communication between Black and Caucasian patients and their transplant providers during transplant evaluation consultations. They want to see how different types of communication affect patient outcomes and living donor transplant outcomes. The

Who is the study for?

This trial is for Black or Caucasian adults who speak English and are being evaluated for a kidney transplant at specific hospitals. It includes patients with limited English if they use a translator, but not those treated offsite or who've had previous transplants. Transplant team members involved in patient evaluations can also participate unless they decline audio recording of consultations.Check my eligibility

What is being tested?

The study aims to improve how transplant providers communicate with patients about living donor kidney transplants. It will record consultations, survey participants, and then train providers based on these insights. The effect of this training on the number of living donor inquiries, evaluations, and actual transplants will be measured.See study design

What are the potential side effects?

Since this trial focuses on communication training rather than medical treatment, there are no direct physical side effects expected from participating in the study itself.

EPPComm Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, 4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Live donor evaluations

Live donor inquiries

Live donor kidney transplant

EPPComm Trial Design

1Treatment groups

Experimental Treatment

Group I: EPPCom Provider TrainingExperimental Treatment1 Intervention

A highly engaging and interactive 60-minute, in-person communication skills training program will be developed as part of this project. Participating transplant providers will complete a brief online survey before (pre) and after (post) participating in the training.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor

297 Previous Clinical Trials

82,780 Total Patients Enrolled

St. Barnabas Medical CenterOTHER

12 Previous Clinical Trials

2,739 Total Patients Enrolled

Francis Weng, MDPrincipal InvestigatorSt. Barnabas Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for the total number of participants who can enroll in this clinical trial?

"Indeed, the details on clinicaltrials.gov affirm that this research study is presently seeking participants. Initially shared on January 1st, 2024, and most recently revised on April 8th, 2024, the trial aims to recruit a total of 193 individuals from two distinct sites."

Answered by AI

Are there currently any available slots for new participants in this medical trial?

"Indeed, the details on clinicaltrials.gov indicate that this investigation is actively searching for eligible individuals. First uploaded on January 1st, 2024 and most recently modified on April 8th, 2024, this trial aims to enroll a total of 193 participants across two designated sites."

Answered by AI

Recent research and studies

American Journal of TransplantationJournal

A Smartphone App for Increasing Live Organ Donation

Kumar, K., E. A. King, A. D. Muzaale, J. M. Konel, K. A. Bramstedt, A. B. Massie, D. L. Segev, and A. M. Cameron. 2016. “A Smartphone App for Increasing Live Organ Donation”. American Journal of Transplantation. Wiley. doi:10.1111/ajt.13961.

Journal of Biomedical InformaticsJournal

Research Electronic Data Capture (redcap)—a Metadata-driven Methodology and Workflow Process for Providing Translational Research Informatics Support

Harris, Paul A., Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, and Jose G. Conde. 2009. “Research Electronic Data Capture (redcap)—a Metadata-driven Methodology and Workflow Process for Providing Translational Research Informatics Support”. Journal of Biomedical Informatics. Elsevier BV. doi:10.1016/j.jbi.2008.08.010.

clinicaltrials.govStudy

Increasing Equity in Live Donor Kidney Transplantation Through Effective Patient-Provider Communication

Heather Gardiner (Traino) 2024. "Increasing Equity in Live Donor Kidney Transplantation Through Effective Patient-Provider Communication". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06182475.

All > Kidney Transplant